PUBLICATIES NEFROLOGIE 2013 Pagina

Size: px
Start display at page:

Download "PUBLICATIES NEFROLOGIE 2013 Pagina 1 19 6 2014"

Transcription

1 PUBLICATIES NEFROLOGIE 2013 Pagina Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Stolk RP, Navis GJ, Bakker SJL, Dullaart RPF. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: The PREVEND Study. J Clin Endocrinol Metab. 2013;98:E Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: A diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis. 2013;S (13) Abdulahad WH, Lepse N, Stegeman CA, Huitema MG, Doornbos-Meer van der B, Tadema HH, Rutgers A, Limburg PC, Kallenberg CGM, Heeringa P. Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis. Arthritis Res Ther. 2013; 24;15:R70 4. Altorf-van der Kuil W, Brink EJ, Boetje M, Siebelink E, Bijlsma S, Engberink MF, Veer PV, Tomé D, Bakker SJL, Baak MA van, Geleijnse JM. Identification of biomarkers for intake of protein from meat, dairy products and grains: a controlled dietary intervention study. Br J Nutr. 2013;110: Andrésdóttir G, Bakker SJL, Hansen HP, Parving HH, Rossing P. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes. Diabet Med. 2013; Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, Bakker SJL, Muller Kobold AC, Oeveren W van, Struck J, Jong PE de, Franssen CFM. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: A cross-sectional study. Am J Kidney Dis. 2013; S : Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, Jong PE de, Westerhuis R, Franssen CFM. Changes in left ventricular diastolic function during hemodialysis sessions. Am J Kidney Dis. 2013;62: Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, Jong PE de, Bakker SJL, Franssen CFM. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clin Res Cardiol. 2013;102: Baia LC, Humalda JK, Vervloet MG, Navis GJ, Bakker SJL, Borst MH de; NIGRAM Consortium. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8: Bakker SJL. Chronic kidney disease: Defining clinical cut-offs for albumin:creatinine ratio. Nat Rev Nephrol. 2013;9: Berg E van den, Engberink MF, Brink EJ, Baak MA van, Gans ROB, Navis GJ, Bakker SJL. Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr. 2013;109: Berndt SI, Gustafsson S, Mägi R, Ganna A, Wheeler E, Feitosa MF et al including Navis GJ. Genomewide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45: Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61: Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJL, Groenier KH, Struck J, Jong PE de, Bilo HJ, Kleefstra N, Gansevoort RT. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia. 2013;56:

2 PUBLICATIES NEFROLOGIE 2013 Pagina Boertien WE, Meijer E, Jong PE de, Bakker SJL, Czerwiec FS, Struck J, Oberdhan D, Shoaf SE, Krasa HB, Gansevoort RT. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int. 2013;84: Brouwers FP, Boer RA de, Harst P van der, Voors AA, Gansevoort RT, Bakker SJL, Hillege HL, Veldhuisen DJ van, Gilst WH van. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34: CLOTS (Clots in Legs Or stockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G including Navis GJ. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382: Damman J, Seelen MAJ. Mannan binding lectin: a two-faced regulator of renal allograft injury? Kidney Int. 2013;83: Deetman PE, Bakker SJL, Dullaart RPF. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12: Dijk S van, Beukel TO van den, Kaptein AA, Honig A, le Cessie S, Siegert CE, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group including collaborators Stegeman CA et al. How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and noncardiovascular mortality in incident patients on chronic dialysis. J Psychosom Res. 2013;74: Eersel ME van, Joosten JMH, Gansevoort RT, Dullaart RPF, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One. 2013;8:e Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol. 2013; 9;168: Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Response to letter by Balta et al. Int J Cardiol. 2013;169: Engel MF, Postma DF, Hulscher ME, Teding van Berkhout F, Emmelot-Vonk MH, Sankatsing S, Gaillard CAJM, Bruns AH, Hoepelman AI, Oosterheert JJ. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J. 2013;41: Franssen CFM, Navis GJ. Chronic kidney disease: RAAS blockade and diastolic heart failure in chronic kidney disease. Nat Rev Nephrol. 2013;9: Gaillard CAJM, Schiffelers RM. Red blood cell: barometer of cardiovascular health? Cardiovasc Res 2013;98: Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA,EN et al including Gansevoort RT; CARDIOGRAM, METASTROKE, LifeLines Cohort Study. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013;22: Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382: Grootendorst DC, Elliott EG, Michels WM, Gansevoort RT, Halbesma N. Lead and CKD. Nephrol Dial Transplant. 2013;28:e

3 PUBLICATIES NEFROLOGIE 2013 Pagina Guo DH, Parikh SJ, Chao J, Pollock NK, Wang X, Snieder H, Navis GJ, Wilson JG, Bhagatwala J, Zhu H, Dong Y. Urinary prostasin excretion is associated withadiposity in nonhypertensive African-American adolescents. Pediatr Res. 2013;74: Gui J, Moore JH, Williams SM, Andrews P, Hillege HL, Harst P van der, Navis GJ, Gilst WH van, Asselbergs FW, Gilbert-Diamond D. A simple and computationally efficient approach to multifactor dimensionality reduction analysis of gene-gene interactions for quantitative traits. PLoS One. 2013;8:e Haas EC de, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker SJL, Roon AM van, Postma A, Wolffenbuttel BH, Hoekstra HJ, Leeuwen FE van, Sleijfer DT, Gietema JA.Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol. 2013;24: Hallan SI, Gansevoort RT. Moderator's view: Estimating glomerular filtration rate--the past, present and future. Nephrol Dial Transplant. 2013;28: Hateren KJ van, Landman GW, Kleefstra N, Groenier KH, Struck J, Navis GJ, Bakker SJL, Houweling ST, Meer K van der, Bilo HJ. The midregional fragment of pro-a-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25). Diabetes Care. 2013;36: Hellemons ME, Lambers Heerspink HJ, Gansevoort RT, Zeeuw D de, Bakker SJL. High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes. J Hypertens. 2013;31: Hoed M den, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segrè AVet al including Navis GJ. Global BPgen Consortium; CARDIoGRAM Consortium; PR GWAS Consortium, Pfeufer A; QRS GWAS Consortium, Sotoodehnia N; QT-IGCConsortium, Newton-Cheh C; CHARGE-AF Consortium, Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45: Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M et al including Gansevoort RT, Navis GJ. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62: Cooper JA, Palmen J, et al including Gansevoort RT, Navis GJ. Secretory phospholipase A2-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62: Hoogen MW van den, Hesselink DA, Son WJ van, Weimar W, Hilbrands LB. Treatment of steroidresistant acute renal allograft rejection with alemtuzumab. Am J Transplant. 2013;13: Hoogen MW van den, Kho MM, Abrahams AC, Zuilen AD van, Sanders JSF, Dijk MC van, Hilbrands LB, Weimar W, Hoitsma AJ. Effect of a single intraoperative high-dose ATG-fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: A randomized study. Exp Clin Transplant. 2013;11: Hu YJ, Berndt SI, Gustafsson S, Ganna A; Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Hirschhorn J, North KE, Ingelsson E, Lin DY including Navis GJ. Meta-analysis of genelevel associations for rare variants based on single-variant statistics. Am J Hum Genet. 2013;93: Jager DJ de, Halbesma N, Krediet RT, Boeschoten EW, le Cessie S, Dekker FW, Grootendorst DC; NECOSAD study group including collaborators Stegeman CA et al. Is the decline of renal function different before and after the start of dialysis? Nephrol Dial Transplant. 2013;28: Joode AAE de, Sanders JSF, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8: Joosten JMH, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44:

4 PUBLICATIES NEFROLOGIE 2013 Pagina Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2013;61: Joosten MM, Gansevoort RT, Mukamal KJ, Harst P van der, Geleijnse JM, Feskens EJ, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97: Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Response to Lowered magnesium in hypertension. Hypertension. 2013;62:e Kallenberg CGM, Stegeman CA, Abdulahad WH, Heeringa P. Pathogenesis of ANCA-associated vasculitis: New possibilities for intervention. Am J Kidney Dis. 2013;62: Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BHR, Dullaart RPF; PREVEND Study Group. Common variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/highdensity lipoprotein cholesterol ratio. J Clin Lipidol. 2013;7: Katta K, Boersema M, Adepu S, Rienstra H, Celie JW, Mencke R, Molema G, Goor H van, Berden JH, Navis GJ, Hillebrands JL, van den Born J. Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction. Am J Pathol. 2013;183: Klein Hesselink EN, Klein Hesselink MS, Bock GH de, Gansevoort RT, Bakker SJL, Vredeveld EJ, Horst-Schrivers AN van der, Horst IC van der, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD. Longterm cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J Clin Oncol. 2013;10;31: Klooster A, Larkin JR, Wiersema-Buist J, Gans ROB, Thornalley PJ, Navis GJ, Goor H van, Leuvenink HG, Bakker SJL. Are brain and heart tissue prone to the development of thiamine deficiency? Alcohol. 2013;47: Klooster A, Hofker HS, Navis GJ, Homan van der Heide JJ, Gans ROB, Goor H van,leuvenink HG, Bakker SJL. Nonesterified fatty acids and development of graft failure in renal transplant recipients. Transplantation. 2013;95: Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D et al including Bakker SJL, Navis GJ; LifeLines Cohort Study; DIAGRAM Consortium; ICBP Consortium; MAGIC Consortium including Navis GJ. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45: Krikken JA, Lely AT, Bakker SJL, Borghuis T, Faas MM, Goor H van, Navis GJ, Bakker WW. Hemopexin activity is associated with angiotensin II responsiveness in humans. J Hypertens. 2013;31: Kuipers J, Usvyat LA, Oosterhuis JK, Dasselaar JJ, Jong PE de, Westerhuis R, Sands JJ, Wang Y, Kotanko P, Franssen CFM. Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. Am J Kidney Dis. 2013;62: Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis GJ, Dullaart RPF. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 2013;226: Kwakernaak AJ, Zelle DM, Bakker SJL, Navis GJ. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24:

5 PUBLICATIES NEFROLOGIE 2013 Pagina Kwakernaak AJ, Toering TJ, Navis GJ. Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics. Nephrol Dial Transplant. 2013;Suppl 4:iv Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, Boer RA de, Navis GJ. Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N- acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. J Hypertens. 2013;31: Lambers Heerspink HJ, Borst MH de, Bakker SJL, Navis GJ. Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat Rev Nephrol. 2013;9: Leer-Buter CC van, Sanders JSF, Vroom HE, Riezebos-Brilman A, Niesters HG. Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations. J Clin Virol. 2013;58: Matsushita K, Ballew SH, Astor BC, Jong PE de, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium. Cohort profile: the chronic kidney disease prognosis consortium. Int J Epidemiol. 2013;42: Metalidis C, Vuuren SH van, Broekhuizen R, Lerut E, Naesens M, Bakker SJL, Wetzels JF, Goldschmeding R, Kuypers DR. Urinary connective tissue growth factor is associated with human renal allograft fibrogenesis. Transplantation. 2013;96: Meijer E, Drenth JP, d'agnolo H, Casteleijn NF, Fijter JW de, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium. Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 2013;S (13) Miloslavsky E, Specks U, Merkel P, Seo P, Spiera R, Langford C, Hoffman GS, Kallenberg CGM et al including Stegeman CA; for the RAVE-ITN Research Group. Clinical outcomes of remission induction therapy for severe ANCA-Associated vasculitis. Arthritis Rheum. 2013;65: Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, Born J van den, Navis GJ, Borst MH de. Urinary vitamin d binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One. 2013;8:e Nauta FL, Scheven L, Meijer E, Oeveren W van, Jong PE de, Bakker SJL, Gansevoort RT. Glomerular and Tubular Damage Markers in Individuals with Progressive Albuminuria. Clin J Am Soc Nephrol. 2013;8: Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, et al including Chronic Kidney Disease Prognosis Consortium. Collaborators including Gansevoort RT, Jong PE de. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Fried LF, Newman AB, Katz R, Satterfield S, Harris TB, Sarnak MJ, Siscovick D, Shlipak MG. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol. 2013;23: Özyilmaz A, Bakker SJL, Zeeuw D de, Jong PE de, Gansevoort RT; PREVEND Study Group. Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. Nephrol Dial Transplant. 2013;28: Paul DS, Albers CA, Rendon A, Voss K, Stephens J; HaemGen Consortium, Harst P van der, Chambers JC, Soranzo N, Ouwehand WH, Deloukas P including collaborators Navis GJ et al. Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res. 2013;23:

6 PUBLICATIES NEFROLOGIE 2013 Pagina Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, Kilpeläinen TO, Esko T et al DIAGRAM Consortium, MAGIC Investigators, Hottenga JJ, Prokopenko I, Waite LL, Harris TB, Smith AV, Shuldiner AR et al including Bakker SJL, Navis GJ. Sex-stratified genome-wide association studies Including 270,000 Individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9:e Reznichenko A, Sinkeler SJ, Snieder H, Born J van den, Borst MH de, Damman J, Dijk MC van, Goor H van, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJL, Seelen MAJ, Navis GJ. SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics.2013;45: Riezebos-Brilman A, Verschuuren EA, Son WJ van, Imhoff GW van, Brügemann J, Blokzijl H, Niesters HG. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol. 2013;58: Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, Hateren van KJ, Struck J, Navis GJ, Bilo HJ, Bakker SJL. Copeptin, a surrogate marker for arginine vasopressin, Is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care. 2013;36: Roscioni SS, Zeeuw D de, Hellemons ME, Mischak H, Zürbig P, Bakker SJL, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Lambers Heerspink HJ. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia. 2013;56: Roth AJ, Ooi JD, Hess JJ, Timmeren MM van, Berg EA, Poulton CE, McGregor J, Burkart M et al including Stegeman CA et al. Epitope specificity determines pathogenicity and detectability in ANCAassociated vasculitis. J Clin Invest. 2013;123: Russcher M, Koch BPC, Nagtegaal JE, Ittersum FJ van, Rasker-de Jong PCM, Hagen EC, Dorp WT van, Gabreëls B, Wildbergh TX, Westerlaken MML van der, Gaillard CAJM, Wee PM ter. Long-term effects of melatonin on quality of life and sleep in hemodialysis patients (Melody study): randomized controlled trial. Br J Clin Pharmacol. 2013;76: Scheven L, Halbesma N, Jong PE de, Zeeuw D de, Bakker SJL, Gansevoort RT. Predictors of progression in albuminuria in the general population: results from the PREVEND cohort. PLoS One. 2013;8:e Scheven L, Velde M van der, Lambers Heerspink HJ, Jong PE de, Gansevoort RT. Isolated microalbuminuria indicates a poor medical prognosis. Nephrol Dial Transplant. 2013;28: Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJL, Kema IP, Gilst WH van, Veldhuisen DJ van, Hillege HL, Boer RA de. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166: Schulz T, Niesing J, Homan van der Heide JJ, Westerhuis R, Ploeg RJ, Ranchor AV. Perceived health after kidney transplantation: a cross-sectional comparison of long-term and short-term cohorts. Transplant Proc. 2013;45: Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369: Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med. 2013;369: Sim X, Jensen RA, Ikram MK, Cotch MF, Li X, MacGregor S, Xie J, Smith AV et al; Wellcome Trust Case Control Consortium 2, Global BPGen Consortium. Collaborators including Navis GJ, Jong PE de. Genetic loci for retinal arteriolar microcirculation. PLoS One. 2013;8:e65804

7 PUBLICATIES NEFROLOGIE 2013 Pagina Sinkeler SJ, Kwakernaak AJ, Bakker SJL, Shahinfar S, Esmatjes E, Zeeuw D de, Navis GJ, Lambers Heerspink HJ, Heerspink. Creatinine excretion rate and mortality in type 2 diabetes and Nephropathy. Diabetes Care. 2013;36: Snijder PM, Berg E van den, Whiteman M, Bakker SJL, Leuvenink HG, Goor H van. Emerging role of gasotransmitters in renal transplantation. Am J Transplant. 2013;13: Souza AW de, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CGM. Is serum HMGB1 a biomarker in ANCA-Associated vasculitis? Arthritis Res Ther.2013;15:R Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, Jong PE de, Navis GJ, Gansevoort RT. Tubular secretion of creatinine in autosomal dominant polycystic Kidney ddisease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations. Am J Kidney Dis. 2013;62: Spithoven EM, Bakker SJl, Kootstra-Ros JE, Jong PE de, Gansevoort RT; DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46: Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM et al including Stegeman CA; RAVE-ITN Research Group. Efficacy of remission-induction regimens for ANCAassociated vasculitis. N Engl J Med. 2013;369: Spithoven EM, Bakker SJL, Kootstra-Ros JE, Jong PE de, Gansevoort RT; for the DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46: Suttorp MM, Hoekstra T, Mittelman M, Ott I, Franssen CFM, Dekker FW. Effect of erythropoiesisstimulating agents on blood pressure in pre-dialysis patients.plos One. 2013;8:e Teunissen-Beekman KF, Dopheide J, Geleijnse JM, Bakker SJL, Brink EJ, Leeuw PW de, Serroyen J, Baak MA van. Blood pressure decreases more after high-carbohydrate meals than after high-protein meals in overweight adults with elevated blood pressure, but there is no difference after 4 weeks of consuming a carbohydrate-rich or protein-rich diet. J Nutr. 2013;143: Tielemans SM, Altorf-van der Kuil W, Engberink MF, Brink EJ, Baak MA van, Bakker SJL, Geleijnse JM. Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies. J Hum Hypertens. 2013;27: Tielemans SM, Geleijnse JM, Baak MA van, Engberink MF, Brink EJ, Jong PE de, Gansevoort RT, Bakker SJL; PREVEND Study Group. Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the PREVEND study. J Hypertens. 2013;31: Toering TJ, Navis GJ, Lely AT. The role of the VEGF-C signaling pathway in preeclampsia? J Reprod Immunol. 2013;100: Torres VE, Gansevoort RT, Czerwiec FS. Tolvaptan in autosomal dominant polycystic kidney disease. N Engl J Med. 2013;368: Tuin J, Sanders JSF, Buhl BM, Beek AP van, Stegeman CA. Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life? Arthritis Res Ther. 2013;15:R Turin TC, Coresh J, Tonelli M, Stevens PE, Jong PE de, Farmer CK, Matsushita K, Hemmelgarn BR. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013;83: Vader P, Fens MH, Sachini N, Oirschot BA van, Andringa G, Egberts AC, Gaillard CAJM, Rasmussen JT, Wijk R van, Solinge WW van, Schiffelers RM. Taxol( )-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor( ) EL. Nanomedicine (Lond). 2013;8: Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol. 2013;8:

8 PUBLICATIES NEFROLOGIE 2013 Pagina Verweij N, Mahmud H, Mateo Leach I, Boer RA de, Brouwers FP, Yu H, Asselbergs FW, Struck J, Bakker SJL, Gansevoort RT, Munroe PB, Hillege HL, Veldhuisen DJ van, Gilst WH van, Silljé HH, Harst P van der. Genome-wide association study on plasmalevels of midregional-proadrenomedullin and C- terminal-pro-endothelin-1. Hypertension. 2013;61: Werkhoven MB van, Damman J, Daha MR, Krikke C, Goor H van, Son WJ van, Hillebrands JL, Dijk MC van, Seelen MAJ. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol. 2013;53: Werkhoven MB van, Damman J, Dijk MC van, Daha MR, Jong IJ de, Leliveld A, Krikke C, Leuvenink HG, Goor H van, Son WJ van, Olinga P, Hillebrands JL, Seelen MAJ. Complement mediated renal inflammation induced by donor brain death: Role of renal C5a-C5aR interaction. Am J Transplant. 2013;13: Zelle DM, Corpeleijn E, Deinum J, Stolk RP, Gans ROB, Navis GJ, Bakker SJL. Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 2013;36: Zelle DM, Kok T, Dontje ML, Danchell EI, Navis GJ, Son WJ van, Bakker SJL, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013;27:E DISSERSATIES Berg van den E Nutrition and cardiovascular health in renal transplant recipients Promtores: prof dr GJ Navis, prof dr ROB Gans Copromotor: dr SJL Bakker Groningen, Alkhalaf A Novel approaches in diabetic Nephropathy Promotores: prof dr GJ Navis, prof dr HJG Bilo Copromotoren: dr SJL Bakker, dr N Kleefstra Groningen, Abbasi A Biomarkers and prediction models for type 2 diabetes and diabetes related outcomes Promotores: prof dr RP Stolk and prof dr GJ Navis Copromotores: dr SJL. Bakker, dr. ir. E. Corpeleijn and r. ir. JW. Beulens Groningen Smink PA Biomarkers and assessment of drug efficacy in cardiovascular disease Promotor: prof dr D de Zeeuw Copromotores: dr HJ Lambers Heerspink, dr SJL Bakker

9 PUBLICATIES NEFROLOGIE 2013 Pagina Groningen Velde van der M Renal risk markers and patient prognosis in chronic kidney disease Promotor: prof dr PE de Jong Copromotor: dr RT Gansevoort Groningen Klooster A Thiamine, fasting and the kidney Promotor: prof dr H van Goor Copromotores: dr SJL Bakker, dr HGD Leuvelink Groningen Zelle DM Lifestyle, the next target for intervention in renal transplant recipients Promotores: prof dr GJ Navis, prof dr RP Stolk Copromotores: dr SJL Bakker, dr ir E Corpeleijn Groningen HOOFDSTUK BOEK

PUBLICATIES NEFROLOGIE 2012

PUBLICATIES NEFROLOGIE 2012 PUBLICATIES NEFROLOGIE 2012 1. Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, Jong PE de, Gans ROB, Rathmann W, Kowall B, Meisinger C, Hillege HL, Stolk RP, Navis GJ, Beulens JW, Bakker SJL. External

More information

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

Publicaties Nefrologie 2014 Pagina 1 31-3-2015

Publicaties Nefrologie 2014 Pagina 1 31-3-2015 Publicaties Nefrologie 2014 Pagina 1 31-3-2015 1. Abbasi A, Stolk RP, Bakker SJL. Identification of relevant biomarkers for type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2:106-7 2. Abbasi A, Corpeleijn

More information

CKD Model Technical Document

CKD Model Technical Document CKD Model Technical Document This report arises from the project EConDA which has received funding from the European Union in the framework of the Health Programme. Project number: 2012 12 13 Introduction

More information

Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013

Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013 Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013 Major risk factors for kidney disease include high blood pressure, diabetes, cardiovascular disease and family history of kidney

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Protein Intake and Diabetic Kidney Disease. Robert C. Stanton Joslin Diabetes Center

Protein Intake and Diabetic Kidney Disease. Robert C. Stanton Joslin Diabetes Center Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.

More information

Dose-Response Effects of Sodium Intake on Blood Pressure

Dose-Response Effects of Sodium Intake on Blood Pressure I Dose-Response Effects of Sodium Intake on 1 +2 NS +1 NS -2 NS +5 NS 0.46 (20) 4.6 () 25.9 (1128) FIGURE I-1 Blood pressure (mm Hg) according to dietary sodium intake in g/d (mmol/d) among 8 normotensive

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical

More information

The role of a low sodium diet in the management of hypertension. Dave Glover Consultant Nephrologist, Wrexham

The role of a low sodium diet in the management of hypertension. Dave Glover Consultant Nephrologist, Wrexham The role of a low sodium diet in the management of hypertension Dave Glover Consultant Nephrologist, Wrexham Salt Aims Is it all a bit Woman s Own / Daily Mail? Current guidelines An idea about salt What

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

Elective Project Report

Elective Project Report Elective Project Report I spent my elective at The Royal Free Hospital, London doing renal medicine. I decided to undertake my elective in renal medicine for two reasons: 1) I am very interested in this

More information

The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection

The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection A Samarawickrama, S Holt, K Nambiar, M Fisher, Y Gilleece Brighton and Sussex

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n

More information

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

Microalbuminuria: An increasingly recognized risk factor for CVD

Microalbuminuria: An increasingly recognized risk factor for CVD Microalbuminuria: An increasingly recognized risk factor for CVD Long known to be associated with kidney disease, the importance of protein in the urine is now becoming recognized as a sensitive, accessible

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the

More information

Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians

Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians Zhiqiang Wang 1 and Wendy E Hoy 1 Centre for Chronic Disease, Department of Medicine, Central Clinical

More information

Type 2 Diabetes Media Fact Sheet

Type 2 Diabetes Media Fact Sheet Type 2 Diabetes Media Fact Sheet 1. Type 2 diabetes: Facts & figures 2. What is type 2 diabetes? 3. Risk factors for type 2 diabetes 4. Complications associated with type 2 diabetes 5. The socio-economic

More information

Update in Contrast Induced Nephropathy

Update in Contrast Induced Nephropathy Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina

More information

Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011

Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011 Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials Version: 1 Date: 5 th December 2011 Study team: C Mary Schooling, CUNY School of Public Health

More information

PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY

PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information

25-hydroxyvitamin D: from bone and mineral to general health marker

25-hydroxyvitamin D: from bone and mineral to general health marker DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate

More information

Small artery tone under control of the endothelium

Small artery tone under control of the endothelium Small artery tone under control of the endothelium On the importance of EDHF and myogenic tone in organ (dys)function Simone K. Gschwend Publication of this thesis was supported by generous contributions

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Package nephro. February 23, 2015

Package nephro. February 23, 2015 Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date 2015-01-31 Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular

More information

Absolute cardiovascular disease risk assessment

Absolute cardiovascular disease risk assessment Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk

More information

Department of Nephrology Dialysis and Transplant, University Hospital Center, Tirana 2

Department of Nephrology Dialysis and Transplant, University Hospital Center, Tirana 2 HIPPOKRATIA 2013, 17, 4: 337-341 ORIGINAL ARTICLE Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare

More information

Dietary treatment of cachexia challenges of nutritional research in cancer patients

Dietary treatment of cachexia challenges of nutritional research in cancer patients Dietary treatment of cachexia challenges of nutritional research in cancer patients Trude R. Balstad 4th International Seminar of the PRC and EAPC RN, Amsterdam 2014 Outline Cancer cachexia Dietary treatment

More information

Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients

Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients Biological Forum An International Journal 6(1): 48-52(2014) ISSN No. (Print): 0975-1130 ISSN No. (Online): 2249-3239 Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Jill Malcolm, Karen Moir

Jill Malcolm, Karen Moir Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are

More information

Albuminuria versus GFR as markers of diabetic CKD progression

Albuminuria versus GFR as markers of diabetic CKD progression Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,

More information

Improving cardiometabolic health in Major Mental Illness

Improving cardiometabolic health in Major Mental Illness Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).

More information

World Kidney Day 11 March 2010: we must act on diabetic kidney disease

World Kidney Day 11 March 2010: we must act on diabetic kidney disease November 11, 2009 Diabetic kidney disease: Act now or pay later Robert C Atkins and Paul Zimmet For the 2010 International Society of Nephrology/International Federation of Kidney Foundations World Kidney

More information

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol

More information

UCSF Kidney Transplant Symposium 2012

UCSF Kidney Transplant Symposium 2012 UCSF Kidney Transplant Symposium 2012 Nutrition Fitness in Kidney Transplant Mary Ellen DiPaola, RD, CDE UCSF Outpatient Dietitian Goal of Nutrition Fitness for Transplant Nutritional guidance of pre-

More information

Albumin and All-Cause Mortality Risk in Insurance Applicants

Albumin and All-Cause Mortality Risk in Insurance Applicants Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH

More information

Chronic kidney disease and cerebral small vessel disease

Chronic kidney disease and cerebral small vessel disease Chronic kidney disease and cerebral small vessel disease M. Arfan Ikram, MD PhD Department of Epidemiology, Radiology, Neurology Erasmus MC Rotterdam, The Netherlands No disclosures Kidney-brain: Two pulsating

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

DATING YOUR GUILD 1952-1960

DATING YOUR GUILD 1952-1960 DATING YOUR GUILD 1952-1960 YEAR APPROXIMATE LAST SERIAL NUMBER PRODUCED 1953 1000-1500 1954 1500-2200 1955 2200-3000 1956 3000-4000 1957 4000-5700 1958 5700-8300 1959 12035 1960-1969 This chart displays

More information

Chronic Kidney Disease (CKD) Getting it right from the start

Chronic Kidney Disease (CKD) Getting it right from the start Chronic Kidney Disease (CKD) Getting it right from the start Increased demand for ESRF Treatment 2007 NZ No of patients on dialysis - 2064 New Patients 461 41% - Type II Diabetes 20% were late referrals

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division

More information

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function JOURNAL OF INSURANCE MEDICINE Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:76 83 MORTALITY Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156 introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Do albuminuria and hs-crp add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?

Do albuminuria and hs-crp add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? NDT Advance Access published January 9, 2012 Nephrol Dial Transplant (2012) 0: 1 9 doi: 10.1093/ndt/gfr634 Original Article Do albuminuria and hs-crp add to the International Diabetes Federation definition

More information

Hypertension and Diabetes

Hypertension and Diabetes Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas

More information

Dietary Composition for Weight Loss and Weight Loss Maintenance

Dietary Composition for Weight Loss and Weight Loss Maintenance Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation

More information

Can Common Blood Pressure Medications Cause Diabetes?

Can Common Blood Pressure Medications Cause Diabetes? Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately

More information

A list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.

A list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and obesity History: A 13-year-old girl is seen for a routine clinic follow-up visit. She has been previously healthy, but her growth curve shows increasing body mass index (BMI) percentiles

More information

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,

More information

Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.

Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht. NRS Roadmap Lung Transplantation Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.nl 1. Inventory of Dutch

More information

Extrarenal Manifestations of Polycystic Kidney Disease Part Two of Three

Extrarenal Manifestations of Polycystic Kidney Disease Part Two of Three Online Slide/Audio Symposium 10th Annual Conference on Polycystic Kidney Disease, June 1999. Selected Talks. Web presentation sponsored by an unrestricted educational grant from Sigma-Tau Pharmaceuticals

More information

1.- L a m e j o r o p c ió n e s c l o na r e l d i s co ( s e e x p li c a r á d es p u é s ).

1.- L a m e j o r o p c ió n e s c l o na r e l d i s co ( s e e x p li c a r á d es p u é s ). PROCEDIMIENTO DE RECUPERACION Y COPIAS DE SEGURIDAD DEL CORTAFUEGOS LINUX P ar a p od e r re c u p e ra r nu e s t r o c o rt a f u e go s an t e un d es a s t r e ( r ot u r a d e l di s c o o d e l a

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Diagnosis, classification and prevention of diabetes

Diagnosis, classification and prevention of diabetes Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3

More information

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ «Η ΔΙΑΤΡΟΦΗ ΣΤΗΝ ΥΓΕΙΑ ΚΑΙ ΣΤΗ ΝΟΣΟ» Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου Γεώργιος Ντάιος Παθολογική Κλινική Πανεπιστημίου Θεσσαλίας Stroke Statistics

More information

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Research Journal of Pharmaceutical, Biological and Chemical Sciences Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,

More information

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels Take a moment Confer with your neighbour And try to solve the following word

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW

Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW IT`S HARD TO GIVE GENERAL ADVICE! ``The Elderly`` Heterogeneous group ;widely varying

More information

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by

More information

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much?

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much? Focus on CME at the University of Saskatchewan Microalbuminuria: So What s a Little Protein? By Judith T. Klassen, BSc, MD, FRCPC University of Saskatchewan Practical Management of Common Medical Problems

More information

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria )

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria ) 2006 17 99-105 2006 20-40% ( ESRD ) 30 299 mg ( ) ( 300 mgday ) DCCBs ) dihydropyridine calcium channel blockers ( non- DCCBs ( -blockers ( diuretics ) 10%) 0.8 ( 60 mlmin per 1.73 m 2 30 mlmin per 1.73

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Psychosocial and medical determinants of long-term patient outcomes

Psychosocial and medical determinants of long-term patient outcomes Psychosocial and medical determinants of long-term patient outcomes A specific focus on patients after kidney transplantation and with haemophilia Lucia Prihodova Copyright 2014 Lucia Prihodova Copyright

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections. National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.

Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. UIC study finds subjects on Isagenix products lost more body fat, lost more visceral fat, showed greater adherence,

More information

Outline Introduction Oidti Oxidative damage Antioxidants properties Antioxidants and antiaging interventions Hormonal therapy Benefits of DHEA, testos

Outline Introduction Oidti Oxidative damage Antioxidants properties Antioxidants and antiaging interventions Hormonal therapy Benefits of DHEA, testos Anti-Aging Aging g Medications What is the Evidence? Sixth Annual Family Medicine Conference Crown Plaza November 11, 2007 Presented by : Jad J. Sakr, Pharm.D. Outline Introduction Oidti Oxidative damage

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information